NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
2024-05-31 8:04:46 PM
|
Chg.
-0.460
|
Volume |
Bid9:59:59 PM |
Ask9:59:59 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
54.980EUR
|
-0.83%
|
565 Turnover: 31,043.460 |
54.960Bid Size: 100 |
55.280Ask Size: 100 |
15.28 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
74.50% |
IPO date: |
2000-11-20 |